Kennebec Savings Bank Takes $819,000 Position in Danaher Co. (NYSE:DHR)

Kennebec Savings Bank bought a new position in Danaher Co. (NYSE:DHR - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,945 shares of the conglomerate's stock, valued at approximately $819,000.

A number of other hedge funds and other institutional investors have also modified their holdings of DHR. Norden Group LLC purchased a new position in shares of Danaher in the first quarter worth approximately $276,000. Concurrent Investment Advisors LLC boosted its holdings in Danaher by 17.5% during the first quarter. Concurrent Investment Advisors LLC now owns 2,169 shares of the conglomerate's stock valued at $542,000 after acquiring an additional 323 shares during the period. Meeder Asset Management Inc. grew its stake in shares of Danaher by 14.3% in the first quarter. Meeder Asset Management Inc. now owns 1,231 shares of the conglomerate's stock worth $307,000 after acquiring an additional 154 shares during the last quarter. Avantax Advisory Services Inc. increased its stake in Danaher by 5.0% during the first quarter. Avantax Advisory Services Inc. now owns 24,580 shares of the conglomerate's stock valued at $6,138,000 after acquiring an additional 1,171 shares during the period. Finally, Bleakley Financial Group LLC boosted its position in shares of Danaher by 6.9% during the 1st quarter. Bleakley Financial Group LLC now owns 35,205 shares of the conglomerate's stock valued at $8,791,000 after acquiring an additional 2,264 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company's stock, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 11.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Evercore ISI boosted their price objective on Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. TD Cowen upped their price target on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. KeyCorp boosted their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a report on Wednesday, October 23rd. Raymond James dropped their price target on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Finally, UBS Group reduced their price target on shares of Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and a consensus target price of $287.16.

Danaher Stock Performance

NYSE DHR traded down $2.33 on Monday, hitting $243.06. 1,133,776 shares of the stock traded hands, compared to its average volume of 2,736,702. The business's fifty day moving average is $264.89 and its two-hundred day moving average is $260.84. Danaher Co. has a 12 month low of $193.75 and a 12 month high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a market capitalization of $175.56 billion, a price-to-earnings ratio of 47.31, a PEG ratio of 4.51 and a beta of 0.85.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.02 earnings per share. As a group, equities analysts anticipate that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher's dividend payout ratio (DPR) is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.